close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CeriBell, Inc. - Common Stock (NQ:CBLL)

24.89 +0.68 (+2.81%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 845,353
Open 24.69
Bid (Size) 19.99 (500)
Ask (Size) 25.30 (100)
Prev. Close 24.21
Today's Range 24.45 - 25.33
52wk Range 10.85 - 25.33
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push ↗
CeriBell (NASDAQ:CBLL) outlined its plans to expand its brainwave-monitoring platform beyond seizure detection, pointing to new products for delirium, pediatric patients and eventually stroke as it... 
Via MarketBeat
News headline image
CeriBell (CBLL) Q2 2026 Earnings Call Transcript ↗
Revenue surged 33% as hospital accounts expanded and delirium reimbursement neared launch. 
Via The Motley Fool
Topics Earnings Intellectual Property World Trade

Performance

YTD
+16.9%
+16.9%
1 Month
+35.1%
+35.1%
3 Month
+37.5%
+37.5%
6 Month
+24.8%
+24.8%
1 Year
+111.1%
+111.1%

More News

Read More
News headline image
CeriBell Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings World Trade
Ceribell Inc (NASDAQ:CBLL) Q1 Revenue Beats Estimates, Net Loss Widens, Full-Year Guidance Raised ↗
Via Chartmill
Ceribell Inc (NASDAQ:CBLL) Reports Strong Q4 Revenue Beat and Provides 2026 Outlook ↗
Via Chartmill
News headline image
Ceribell Reports Second Quarter 2026 Financial Results
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
From Ceribell
Via GlobeNewswire
News headline image
CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit Records ↗
Via MarketBeat
News headline image
CeriBell Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
CeriBell (CBLL) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics World Trade
News headline image
Ceribell Reports First Quarter 2026 Financial Results
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026
From Ceribell
Via GlobeNewswire
News headline image
CeriBell (CBLL) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings World Trade
News headline image
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in Upcoming March Investor Conferences
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution
From Ceribell
Via GlobeNewswire
News headline image
AI Diagnostics: The End of the High-Cost Imaging Era
From Equity Insider
Via GlobeNewswire

Frequently Asked Questions

Is CeriBell, Inc. - Common Stock publicly traded?
Yes, CeriBell, Inc. - Common Stock is publicly traded.
What exchange does CeriBell, Inc. - Common Stock trade on?
CeriBell, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CeriBell, Inc. - Common Stock?
The ticker symbol for CeriBell, Inc. - Common Stock is CBLL on the Nasdaq Stock Market
What is the current price of CeriBell, Inc. - Common Stock?
The current price of CeriBell, Inc. - Common Stock is 24.89
When was CeriBell, Inc. - Common Stock last traded?
The last trade of CeriBell, Inc. - Common Stock was at 08/19/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.